Structure-based design in drug discovery - The application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands

Expert Opinion on Investigational Drugs

Volumn 6, Issue 4, 1997, Pages 349-365

  Pritchard, M C ^a   Raphy, J ^a   Singh, L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; ALPHA METHYL N [(TRICYCLO[3.3.1.1 3,7]DEC 2 YLOXY)CARBONYL]TRYPTOPHYL DEXTRO 3 BENZYL BETA ALANINE; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CYCLO(GLUTAMINYLTRYPTOPHYLPHENYLALANYLGLYCYLLEUCYLMETHIONYL); L 659874; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; NEUROPEPTIDE RECEPTOR; PD 119671; PD 136450; PD 142654; PD 142803; PD 142806; PD 142898; PD 143020; PD 143041; PD 143231; PD 144326; PD 147714; PD 148067; PD 149164; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANXIETY; CLINICAL TRIAL; DRUG DESIGN; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; HUMAN; NERVOUS SYSTEM; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION; TECHNIQUE;

EID: 0030901731     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.4.349     Document Type: Review

References (86)